Renascience (TSE:4889) Total Operating Expense: 円421.09 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4889 Renascience Inc TSE:4889
53 GF Score
Price 円1,522.00
GF Value 円331.42
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Renascience Total Operating Expense?

Renascience TSE:4889 -2.25% 53 Total Operating Expense is 円421.09 Mil as of Mar. 2026. GuruFocus rates TSE:4889 with a GF Score™ of 53/100 and a GF Value™ of 円331.42 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Renascience's Total Operating Expense for the six months ended in Mar. 2026 was 円224.24 Mil. Renascience's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was 円421.09 Mil.

Renascience Total Operating Expense Related Terms

Renascience Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Renascience's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Renascience Total Operating Expense Chart

Renascience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Operating Expense
Get a 7-Day Free Trial 291.81 434.17 417.98 307.77 421.09

Renascience Semi-Annual Data
Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 229.73 145.49 162.28 196.86 224.24
TSE:4889
53GF Score
Renascience Inc TSE:4889
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Renascience Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円421.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of 円421.09 Mil mean?
Renascience (TSE:4889) has a Total Operating Expense of 円421.09 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Renascience and its competitors.
Is Renascience's Total Operating Expense too high?
Renascience's current Total Operating Expense is 円421.09 Mil. Overall, Renascience has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Renascience's Total Operating Expense compare to ABT and SYK?
Renascience's Total Operating Expense of 円421.09 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Renascience and its competitors. Renascience's current Total Operating Expense is 円421.09 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Renascience stock overvalued right now?
Based on GuruFocus' analysis, Renascience (TSE:4889) is currently considered Significantly Overvalued. The stock's GF Value™ is 円331.42, compared to a current price of 円1,522.00 — trading 359.2% above its estimated fair value. The current Total Operating Expense is 円421.09 Mil. Renascience's overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Renascience (TSE:4889), the current Total Operating Expense is 円421.09 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Renascience (TSE:4889) Overvalued in 2026?

Based on GuruFocus' analysis, Renascience stock appears to be overvalued. The current stock price of 円1,522.00 is trading 359.2% above its estimated GF Value™ of 円331.42. GuruFocus considers Renascience to be Significantly Overvalued.

Key valuation signals for TSE:4889:

  • Total Operating Expense: 円421.09 Mil
  • GF Value™: 円331.42 vs. price of 円1,522.00 (359.2% above fair value)
  • GF Score™: 53/100 with 3 warning signs

No single metric tells the full story. See the TSE:4889 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Renascience Business Description

Address 2-1 Seiryo-cho, Aoba-ku, Miyagi, Sendai, JPN, 103-0023
Renascience Inc is engaged in the Development and commercialization of pharmaceuticals, medical devices, pieces of software as a medical device (SaMD) utilizing AI, etc.
53GF Score

Get the complete analysis for TSE:4889

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,522.00
Price
円331.42
GF Value